[1]
V. Ankudavičius, “UPDATED ALEX TRIAL RESULTS: ALECTINIB▼ – NEW STANDART IN TREATMENT ALK POSITIVE NONSMALL CELL LUNG CANCER”, PIA, vol. 2, no. 2, pp. 152-155, Sep. 2018.